Redundancy of age restrictions for MM treatment

Autologous stem cell transplantation (ASCT) for multiple myeloma (MM) patients has often been capped at 65 years of age. However, Mohamad Mohty, MD, PhD, of the University Pierre & Marie Curie, Pa... Author: VJHemOnc Added: 07/25/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts